eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

BOOTS COMPANY PLC
1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 306
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 05/05/2011
SPC Boots Aspirin and Codeine Tablets BP

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
Date of revision of text on the SPC:   01-Nov-2010
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Codeine Breastfeeding warnings.
Updated on 28/06/2010 and displayed until 05/05/2011
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   01-Oct-2009
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
The changes were to sections 4.1 and 4.4 regarding codeine safety warnings and to section 6.5 to remove pack sizes above 32.$0$0$0
Updated on 11/02/2008 and displayed until 28/06/2010
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   08/2005
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
To update the SPC and product labelling with regard to addiction and overuse headache as requested in the MHRA letter dated 05/07/05.
Updated on 29/10/2004 and displayed until 11/02/2008
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
Updated on 06/12/2002 and displayed until 29/10/2004
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 05/12/2002 and displayed until 06/12/2002
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 11/11/2002 and displayed until 05/12/2002
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.8 - Undesirable Effects
Updated on 04/03/2002 and displayed until 11/11/2002
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
  aspirin
  codeine phosphate